BioSpace News Archive

According to a report by Transparency Market Research, the global cleanroom consumable market is expected to rise at a healthy CAGR of 4.15% during 2017 to 2023.

The global healthcare sector is advancing at a rapid rate, as it is integrating advanced technologies and various software to simplify working in it.

Karyopharm Therapeutics posted positive Phase III results in multiple myeloma and announced it is planning a regulatory submission in the second quarter of this year for its combination of Xpovio, Velcade and Dexamethasone.

Polarean Imaging plc announces that it has issued 232,010 new ordinary shares of £0.00037 each in the capital of the Company at par value, following the exercise of warrants by Amphion Innovations plc.

Oculis S.A., a clinical-stage biopharmaceutical company whose mission is to develop novel topical treatments for ophthalmic diseases, announced the appointment of Marcia de Souza Lima, M.D., M.I.P.P., as Chief Medical Officer.

According to recently published report by Future Market Insights, the global atopic dermatitis treatment market size is expected to reach US$ 26 Bn by 2029.

According to a recently published report by Future Market Insights, the global drug of abuse testing market was valued at US$ 1.3 Bn in 2019.

According to estimates by Transparency Market Research, the global vaccines market was worth about US$28.0 bn in 2016.

Qiagen manufactures diagnostic tests for a variety of diseases including cancer and, currently, the coronavirus that causes COVID-19.

Acacia Pharma Group plc, a hospital pharmaceutical company focused on the development and commercialization of new products aimed at improving the care of patients undergoing significant treatments such as surgery, other invasive procedures or cancer chemotherapy, announces the following changes to its Officers and Board of Directors.